Cargando…
High levels of Nm23 gene expression in advanced stage of thyroid carcinomas.
The product of Nm23 gene has been proposed as a candidate tumour metastasis suppressor protein. A strong association has been observed between reduced expression of Nm23 gene and acquisition of metastatic behaviour in some tumour cells including breast cancer and melanoma, but not in others such as...
Autores principales: | Zou, M., Shi, Y., al-Sedairy, S., Farid, N. R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968576/ https://www.ncbi.nlm.nih.gov/pubmed/8394105 |
Ejemplares similares
-
Differential nm23 gene expression at the fetal-maternal interface.
por: Shi, Y., et al.
Publicado: (1994) -
Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas.
por: Shi, Y., et al.
Publicado: (1996) -
Tissue inhibitor of metalloproteinases-1 (TIMP-1) mRNA is elevated in advanced stages of thyroid carcinoma
por: Shi, Y, et al.
Publicado: (1999) -
Mutation of the nm23 gene, loss of heterozygosity at the nm23 locus and K-ras mutation in ovarian carcinoma: correlation with tumour progression and nm23 gene expression.
por: Mandai, M., et al.
Publicado: (1995) -
Expression of nm23-H1 and nm23-H2 protein in endometrial carcinoma.
por: Watanabe, J., et al.
Publicado: (1995)